Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma

Conditions: Multiple Myeloma Interventions: Drug: Ruxolitinib Oral Tablet [Jakafi]; Drug: Lenalidomide; Drug: Methylprednisolone Sponsors: Oncotherapeutics; Incyte Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials